Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-08-09 to 2023-08-30
Current total value of award: $36541.48
Description: 4561805265!HEMLIBRA 150 MG/ML VIALML